Immune reconstitution inflammatory syndrome after cessation of the tumor necrosis factor α blocker adalimumab in cryptococcal pneumonia

References

Page 1

	Year	Citations
Granulomatous Infectious Diseases Associated with Tumor Necrosis Factor Antagonists Robert S. Wallis, Michael S. Broder, Jia Yi Karen Wong, Clinical Infectious Diseases	2004	976
Immune Reconstitution in HIV‐Infected Patients Hans H. Hirsch, Gilbert R. Kaufmann, Manuel Battegay Clinical Infectious Diseases	2004	325
An Immune Reconstitution Syndrome-Like Illness Associated withCryptococcus neoformans Infection in Organ Transplant Recipients Nikhil Singh, Olivier Lortholary, Barbara D. Alexander, Clinical Infectious Diseases	2005	247
Tumor‐Necrosis‐Factor Blockers: Differential Effects on Mycobacterial Immunity Oluwabunmi Y. Saliu, Carolina Sofer, Dana Stein, The Journal of Infectious Diseases	2006	181
Paradoxical Response to Antituberculous Therapy in Infliximab-Treated Patients with Disseminated Tuberculosis Carolina García‐Vidal, Stéphanie Fernandez, J Lacasa, Clinical Infectious Diseases Translational MedicinePulmonary TuberculosisTuberculosis PreventionInfliximab-treated PatientsDisseminated Tuberculosis	2005	178
Immune reconstitution inflammatory syndrome in cancer patients with pulmonary aspergillosis recovering from neutropenia: Proof of principle, description, and clinical and research implications Marisa H. Miceli, Johan Maertens, Kristel Buvé, Cancer	2007	159
A Patient with De Novo Tuberculosis during Anti-Tumor Necrosis Factor-- Therapy Illustrating Diagnostic Pitfalls and Paradoxical Response to Treatment Sandra M. Arend, Eliane M.S. Leyten, Willeke P. J. Franken, Clinical Infectious Diseases	2007	73
Cryptococcal Immune Reconstitution Inflammatory Syndrome following Alemtuzumab Therapy Paul R. Ingram, Rebecca Howman, Michael F. Leahy, Clinical Infectious Diseases InflammationPrimary ImmunodeficiencyAntiretroviral TherapyAutoimmune DiseaseHuman Retrovirus	2007	44

Page 1